Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Segondy

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Medical Virology|December 1, 1996
Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasmaJ Coste, B Montes, J Reynes, et al.
The Journal of Infectious Diseases|July 1, 1991
Spontaneous in vitro secretion of antibody to cytomegalovirus (CMV) by human peripheral blood mononuclear cells: a new approach to studying the CMV-immune system interactionJ P Vendrell, M Segondy, A M Fournier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1990
Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infectionM Segondy, J P Vendrell, J Reynes, et al.
Journal of Clinical Microbiology|August 1, 1992
In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humansJ P Vendrell, A M Conge, M Segondy, et al.
The European Respiratory Journal|June 1, 1988
Approaches to the diagnosis of viral pneumonias in the immunocompromised host: the importance of assaying cytopathogenic viral effects in bronchoalveolar lavage cellsP Chanez, P Aubas, M Segondy, et al.
Medecine Et Maladies Infectieuses|October 22, 2016
Characteristics of HPV infection in women at risk in Western AlgeriaN Masdoua, L Boublenza, H Hassaine, et al.
AIDS (London, England)|October 6, 1999
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI GroupI Pellegrin, J Izopet, J Reynes, et al.
Lancet (London, England)|July 3, 1993
In-vitro synthesis of antibodies to Toxoplasma gondii by lymphocytes from HIV-1-infected patientsJ P Vendrell, J Reynes, M F Huguet, et al.
Clinical and Experimental Immunology|January 1, 1996
Hepatitis B virus (HBV)-specific in vitro antibody production by peripheral blood mononuclear cells (PBMC) after vaccination by recombinant hepatitis B surface antigen (rHBsAg)J Ducos, A M Bianchi-Mondain, G Pageaux, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapyM Segondy, J Izopet, I Pellegrin, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Medical Virology|December 1, 1996
Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasmaJ Coste, B Montes, J Reynes, et al.
The Journal of Infectious Diseases|July 1, 1991
Spontaneous in vitro secretion of antibody to cytomegalovirus (CMV) by human peripheral blood mononuclear cells: a new approach to studying the CMV-immune system interactionJ P Vendrell, M Segondy, A M Fournier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1990
Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infectionM Segondy, J P Vendrell, J Reynes, et al.
Journal of Clinical Microbiology|August 1, 1992
In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humansJ P Vendrell, A M Conge, M Segondy, et al.
The European Respiratory Journal|June 1, 1988
Approaches to the diagnosis of viral pneumonias in the immunocompromised host: the importance of assaying cytopathogenic viral effects in bronchoalveolar lavage cellsP Chanez, P Aubas, M Segondy, et al.
Medecine Et Maladies Infectieuses|October 22, 2016
Characteristics of HPV infection in women at risk in Western AlgeriaN Masdoua, L Boublenza, H Hassaine, et al.
AIDS (London, England)|October 6, 1999
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI GroupI Pellegrin, J Izopet, J Reynes, et al.
Lancet (London, England)|July 3, 1993
In-vitro synthesis of antibodies to Toxoplasma gondii by lymphocytes from HIV-1-infected patientsJ P Vendrell, J Reynes, M F Huguet, et al.
Clinical and Experimental Immunology|January 1, 1996
Hepatitis B virus (HBV)-specific in vitro antibody production by peripheral blood mononuclear cells (PBMC) after vaccination by recombinant hepatitis B surface antigen (rHBsAg)J Ducos, A M Bianchi-Mondain, G Pageaux, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapyM Segondy, J Izopet, I Pellegrin, et al.
Pageof 5